Merrion, Novo Nordisk To Collaborate On Oral Insulin Analogues
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite giving up on inhaled insulin earlier this year, deal continues Novo Nordisk’s focus on enhancements to insulin formulation and delivery.